Search & Analyze

Innova Captab Ltd.

HealthcarePharmaceuticals & Drugs

www.innovacaptab.com BSE: 544067NSE: INNOVACAP

₹1,123.00BSE0.62%

16 Sep, 4:01 PM

₹1,123.00

₹6.53K Cr

41.79

5.75

13.75%

₹1,158.75

₹1,084.70

₹1,230.35

₹608.25

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.40	4,44,716.74	0.87	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.41	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.58	1,83,453.32	0.78	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.29	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.62	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	95.03	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.78	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
Innova Captab Ltd. INNOVACAP	1,123.00	41.79	6,530.80	0.18	44.13	42.27%	470.85	33.94%	15.04

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	294.27	318.20	316.46	314.74	351.54	380.38	450.29	447.80	470.85
Expenses	252.09	268.47	269.90	267.06	299.44	328.52	380.90	382.71	397.73
	42.18	49.73	46.56	47.68	52.10	51.86	69.40	65.09	73.12
	14.33%	15.63%	14.71%	15.15%	14.82%	13.63%	15.41%	14.54%	15.53%
	2.12	2.22	4.33	3.38	4.48	4.19	1.65	1.56	2.01
Interest	0.14	0.15	0.17	1.95	2.86	5.50	3.95	4.59	4.43
	4.85	4.99	5.13	9.80	11.05	11.32	11.42	11.39	11.71
	39.31	46.81	45.59	39.31	42.68	39.24	55.68	50.68	58.99
	25.01%	25.22%	24.97%	27.33%	27.33%	24.38%	24.30%	20.38%	25.19%
	29.48	35.00	34.20	28.57	31.01	29.67	42.15	40.35	44.13
	5.15	6.12	5.98	4.99	5.42	5.18	7.37	7.05	7.71

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	808.37	940.07	1,083.66	1,265.57	1,658.98
	800.53	926.38	1,081.31	1,243.68	1,630.02
EXPENDITURE :
Increase/Decrease in Stock	5.49	0.17	-3.32	-24.94	-11.00
Raw Material Consumed	523.97	552.46	582.67	664.30	838.16
Power & Fuel Cost	7.91	9.51	20.39	27.14	39.12
Employee Cost	40.46	54.80	90.66	116.78	167.20
Other Manufacturing Expenses	100.72	152.24	177.68	207.40	267.04
General and Administration Expenses	15.22	23.39	32.63	36.83	56.98
Selling and Distribution Expenses	6.93	14.24	15.67	18.38	30.75
Miscellaneous Expenses	3.81	5.93	10.47	11.63	10.14
	704.51	812.73	926.85	1,057.52	1,398.39
Operating Profit (Excl OI)	96.02	113.65	154.45	186.16	231.63
	2.88	9.20	12.49	12.05	18.71
	98.90	122.85	166.94	198.20	250.34
Interest	5.68	19.97	21.46	2.41	16.90
PBDT	93.22	102.87	145.49	195.80	233.44
	7.50	11.08	15.96	24.78	45.18
Profit Before Taxation & Exceptional Items	85.72	91.80	129.53	171.02	188.26
	85.72	91.80	129.53	171.02	188.26
Provision for Tax	21.77	23.84	35.18	42.76	47.35
	63.95	67.95	94.35	128.26	140.92
Extra items				0.00	0.00
Other Consolidated Items	-0.17
Consolidated Net Profit	63.79	67.95	94.35	128.26	140.92
Profit Balance B/F	132.78	196.56	228.46	324.70	453.22
Appropriations	196.56	264.52	322.81	452.95	594.14
Equity Dividend %					20.00%
	531.54	14.16	16.49	22.41	24.63
Adjusted EPS	13.29	14.16	16.49	22.41	24.63

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	12.00	48.00	57.23	57.23	57.23
Total Reserves	196.61	228.51	773.67	902.19	1,033.57
Reserve excluding Revaluation Reserve	196.61	228.51	773.67	902.19	1,033.57
Revaluation reserve	0.00		0.00
	208.61	276.51	830.89	959.42	1,090.79
Secured Loans	40.36	62.34	208.20	243.55	214.80
Unsecured Loans	26.99	71.84
Deferred Tax Assets / Liabilities	1.84	3.80	-15.12	0.95	22.85
Other Long Term Liabilities	0.68	9.36	2.32	1.35	1.02
Long Term Provisions	18.23	46.82	9.14	9.91	11.92
Total Non-Current Liabilities	88.10	194.16	204.55	255.75	250.59
Trade Payables	144.80	158.48	179.66	201.80	318.63
Other Current Liabilities	28.31	20.55	57.98	77.29	69.24
Short Term Borrowings	120.09	97.94	23.84	65.65	99.26
Short Term Provisions	22.27	0.58	32.50	31.69	29.55
Total Current Liabilities	315.47	277.55	293.98	376.44	516.68
Total Liabilities	612.17	748.22	1,329.42	1,591.60	1,858.06
Gross Block	205.97	215.53	406.39	901.14	955.72
Less: Accumulated Depreciation	22.93	32.65	48.51	71.27	114.21
Net Block	183.04	182.88	357.88	829.87	841.51
Capital Work in Progress	0.03	21.54	340.79	22.52	15.50
Long Term Investment	0.00		0.00
Long Term Loans & Advances	28.83	101.07	22.00	6.82	16.38
Other Non Current Assets	0.28	0.26	0.50	5.85	39.60
Total Non-Current Assets	212.17	305.75	721.17	865.06	913.00
Currents Investments					41.29
Inventories	128.39	117.32	144.02	208.00	283.26
Sundry Debtors	212.69	265.22	288.49	331.65	437.29
Cash and Bank	2.44	18.88	86.75	68.17	3.87
Other Current Assets	6.41	13.45	8.91	33.21	65.36
Short Term Loans and Advances	50.08	27.61	80.08	78.10	114.01
Total Current Assets	400.00	442.47	608.25	719.12	945.06
Net Current Assets (Including Current Investments)	84.53	164.92	314.27	342.69	428.38
Total Assets	612.17	748.22	1,329.42	1,591.60	1,858.06
Contingent Liabilities	0.07	0.06
Total Debt	198.18	235.19	241.81	336.07	342.67
	1,738.38	57.61	145.20	167.66	190.61
Adjusted Book Value	43.46	57.61	145.20	167.66	190.61

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	85.72	91.80	129.53	171.02	188.26
Adjustment	15.29	25.92	37.16	27.38	57.64
Changes In working Capital	-21.27	-31.06	7.31	-110.84	-103.13
Cash Flow after changes in Working Capital	79.74	86.65	174.00	87.56	142.77
Cash Flow from Operating Activities	58.90	67.12	146.34	63.84	116.52
Cash Flow from Investing Activities	-188.12	-90.84	-498.97	-151.59	-107.12
Cash Flow from Financing Activitie	124.57	27.09	360.83	91.53	-21.72
Net Cash Inflow / Outflow	-4.64	3.37	8.20	3.79	-12.32
Opening Cash & Cash Equivalents	4.80	0.15	3.53	11.73	15.52
Closing Cash & Cash Equivalent	0.15	3.53	11.73	15.52	3.20

Ratios

Valuation

41.79

5.75

25.55

3.73

27.31

198.33

Profitability

13.75

15.04

8.17

13.96

8.49

Leverage & Liquidity

0.31

1.83

12.14

Returns

0.18

0.96

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90	50.90
	22.42	21.62	20.70	20.12	19.90	20.24	20.35	20.37	20.26
	26.68	27.48	28.41	28.99	29.20	28.85	28.76	28.73	28.84
	49.10	49.10	49.10	49.10	49.10	49.10	49.10	49.10	49.10
No. of Shareholders	35,115	32,254	36,692	39,996	41,014	40,245	38,691	36,965	35,881

Corporate Actions

Showing: All

Date	Type	Details
2026-08-18	Board Meeting	Audited Results
2026-08-06	Board Meeting	Quarterly Results
2026-06-04	AGM

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Innova Captab Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Neeharika Shukla

Company Secretary & Compliance Officer

—

Manoj Kumar Lohariwala

Chairman

₹1.48 Cr

Mar '26

Jayant Vasudeo Rao

Whole Time Director

₹19.72 L

Mar '26

Vinay Kumar Lohariwala

Managing Director

₹1.00 Cr

Mar '25

Archit Aggarwal

Non Independent & Non Executive Director

—

Sudhir Kumar Bassi